WO2008097828A8 - Method for isolating mesenchymal stromal cells - Google Patents
Method for isolating mesenchymal stromal cells Download PDFInfo
- Publication number
- WO2008097828A8 WO2008097828A8 PCT/US2008/052759 US2008052759W WO2008097828A8 WO 2008097828 A8 WO2008097828 A8 WO 2008097828A8 US 2008052759 W US2008052759 W US 2008052759W WO 2008097828 A8 WO2008097828 A8 WO 2008097828A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- stromal cells
- mesenchymal stromal
- isolating mesenchymal
- isolating
- mscs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0665—Blood-borne mesenchymal stem cells, e.g. from umbilical cord blood
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Developmental Biology & Embryology (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The present invention relates to an isolated population of non-cancerous cells which have been enriched for ganglioside GD2 mesenchymal stromal cells (MSCs). Methods for isolating GD2+ MSCs and using the same in therapeutic applications are also provided.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US88784407P | 2007-02-02 | 2007-02-02 | |
US60/887,844 | 2007-02-02 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2008097828A2 WO2008097828A2 (en) | 2008-08-14 |
WO2008097828A3 WO2008097828A3 (en) | 2008-11-13 |
WO2008097828A8 true WO2008097828A8 (en) | 2009-09-03 |
Family
ID=39682340
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2008/052759 WO2008097828A2 (en) | 2007-02-02 | 2008-02-01 | Method for isolating mesenchymal stromal cells |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2008097828A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA029577B1 (en) | 2011-07-06 | 2018-04-30 | Селл Терапи Лимитед | Progenitor cells of mesodermal lineage |
EP3807398A4 (en) * | 2018-06-14 | 2022-03-09 | Abraham J and Phyllis Katz Cord Blood Foundation | Isolation of mesenchymal stromal cells from umbilical cord blood |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2444706C (en) * | 2001-04-20 | 2015-06-30 | Children's Hospital Of Orange County | Isolation of neural stem cells using gangliosides and other surface markers |
-
2008
- 2008-02-01 WO PCT/US2008/052759 patent/WO2008097828A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2008097828A3 (en) | 2008-11-13 |
WO2008097828A2 (en) | 2008-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2801536C (en) | Protein concentrates and isolates, and processes for the production thereof from macroalgae and/or microalgae | |
WO2010017216A3 (en) | Mesenchymal stromal cell populations and methods of isolating and using same | |
WO2009120762A3 (en) | Human cardiovascular progenitor cells | |
WO2008121894A3 (en) | Endogenous expression of hla-g and/or hla-e by mesenchymal cells | |
BR112013002811A8 (en) | simplified basic means for human pluripotent cell culture | |
WO2010141801A3 (en) | Reprogramming t cells and hematophietic cells | |
WO2009076676A3 (en) | Compositions and methods for producing isoprene | |
WO2008129563A3 (en) | Human mesenchymal stem cells and preparation thereof | |
AU2012274478A8 (en) | Method for amplifying NK cells | |
WO2011121454A3 (en) | Direct nucleic acid analysis | |
WO2010039802A3 (en) | Methods and compositions for isolating nucleic acid | |
WO2008063675A3 (en) | Endodermal progenitor cells | |
WO2010093655A3 (en) | Enhanced method for producing stem-like cells from somatic cells | |
WO2009092005A3 (en) | Methods of generating cardiomyocytes and cardiac progenitors and compositions | |
MX2009013170A (en) | Silica particles and methods of making and using the same. | |
WO2010097793A3 (en) | Isolated populations of renal stem cells and methods of isolating and using same | |
WO2009114724A3 (en) | COMPOSITIONS COMPRISING NUCLEAR FACTOR-KAPPA B (NF-ĸB) SIRNA AND METHODS OF USE | |
WO2010141622A3 (en) | Method to isolate, identify, and use embryonic stem cells directed to forebrain interneuron fate | |
WO2006102209A3 (en) | Cd34(+) cells and their methods of use | |
WO2012057567A3 (en) | Kit for screening for skin-activating substances and comprising the klotho gene, and method for screening for skin-activating substances using same | |
WO2012075462A3 (en) | Methods and compositions for treatment of muscular dystrophy | |
WO2009058451A3 (en) | Neuronal progenitor cells and methods of derivation and purification of neuronal progenitor cells from embryonic stem cells | |
HK1139402A1 (en) | Process for the preparation of 2-substituted-5-(1-alkylthio) alkylpyridines | |
WO2008097828A8 (en) | Method for isolating mesenchymal stromal cells | |
WO2011097242A3 (en) | Methods of isolating and culturing mesenchymal stem cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08728798 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08728798 Country of ref document: EP Kind code of ref document: A2 |